A. Abbott

Stroke · 2009

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Whom A. Abbott trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Michael Smithson

Papers from A. Abbott's perspective

Ordered by how strongly the researchers A. Abbott trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Inheritance and drug response. (New England Journal of Medicine)
  2. Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial (British medical journal)
  3. Clinical importance of the cytochromes P450. (The Lancet)
  4. Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients (AIDS (London))
  5. Drug metabolism and variability among patients in drug response. (New England Journal of Medicine)
  6. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2 (Nature)
  7. Orphan Nuclear Receptors Constitutive Androstane Receptor and Pregnane X Receptor Share Xenobiotic and Steroid Ligands* (Journal of Biological Chemistry)
  8. A 5-month, randomized, placebo-controlled trial of galantamine in AD (Neurology)
  9. Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism (Clinical Pharmacokinetics)
  10. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression (Nature Genetics)

Their papers